Department of Surgery, Division of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Eur J Cardiothorac Surg. 2013 Feb;43(2):288-92. doi: 10.1093/ejcts/ezs247. Epub 2012 Jul 31.
The resection of thymic tumours requires completeness and may be technically challenging due to the anatomical proximity of the delicate mediastinal structures. An open approach by sternotomy is still recommended in all cases with locally extended disease. Video-assisted thoracoscopic surgery is feasible, but limited by the two-dimensional vision and the impaired mobility of the instruments. We evaluated the da Vinci® Surgical System for the resection of various mediastinal pathologies, particularly thymomas.
Among 105 patients operated on by robotic assisted thoracoscopic surgery (RATS) for mediastinal tumours between 27 August 2004 and 12 July 2011, 20 patients with thymomas were studied prospectively. Of these, 10 males with a median age of 53 years, with a well-circumscribed thymic lesion on computed tomography (CT) and a diameter of <6 cm were resected by RATS alone, and selected ones (n = 3), with a diameter of >6 cm, underwent a hybrid procedure with a contralateral thoracotomy on the side of the main tumour extension. A regular follow-up with chest CT scans was performed every 6 months.
Thymoma resection was complete in all patients. Partial pericardial resection was needed in five and pulmonary resection in two patients. Eighty-five percent of patients had an R0 resection. Histological classifications included thymoma WHO type A (n = 3), AB (n = 8), B1-2 (n = 5) and B3 (n = 4). All B3 thymomas received adjuvant radiotherapy. No intraoperative complications occurred. The median hospitalization time was 5 days (range 2-14 days). There were no local, but two pleural, recurrences. After a median observation time of 26 months, 19 patients (95%) are alive.
Well-circumscribed thymomas can be safely and completely resected with the da Vinci® Surgical System with excellent short- and mid-term outcomes. Selected tumours with large diameters may be resectable using a hybrid procedure combining RATS with a thoracotomy.
胸腺肿瘤的切除需要完整性,由于纵隔结构的精细解剖位置接近,因此可能具有技术挑战性。对于局部扩展疾病的所有病例,仍建议通过胸骨切开术进行开放性方法。电视辅助胸腔镜手术是可行的,但受到二维视觉和器械运动受限的限制。我们评估了达芬奇®手术系统用于切除各种纵隔病变,特别是胸腺瘤。
在 2004 年 8 月 27 日至 2011 年 7 月 12 日期间,通过机器人辅助胸腔镜手术(RATS)对 105 例纵隔肿瘤患者进行手术,其中 20 例患者为胸腺瘤。前瞻性研究。其中,10 例男性,中位年龄 53 岁,胸部 CT 显示边界清楚的胸腺病变,直径<6cm,仅通过 RATS 切除,另外 3 例直径>6cm的患者进行了混合手术,在主要肿瘤延伸的一侧进行了对侧开胸手术。定期进行胸部 CT 扫描以进行常规随访,每 6 个月进行一次。
所有患者的胸腺瘤均完全切除。五例需要部分心包切除,两例需要肺切除。85%的患者行 R0 切除术。组织学分类包括胸腺瘤 WHO 类型 A(n=3)、AB(n=8)、B1-2(n=5)和 B3(n=4)。所有 B3 胸腺瘤均接受辅助放疗。术中无并发症发生。中位住院时间为 5 天(范围 2-14 天)。无局部但有 2 例胸膜复发。中位观察时间为 26 个月后,19 例(95%)患者存活。
使用达芬奇®手术系统可安全、完整地切除边界清楚的胸腺瘤,具有良好的短期和中期结果。对于直径较大的选定肿瘤,可通过结合 RATS 和开胸手术的混合手术切除。